Parkinson DiseaseNCT03214926
Moving Through Glass: An Augmented Reality Device Application for Persons With Parkinson's Disease
A study testing Moving Through Glass intervention in people with Parkinson Disease, run by Syracuse University.
Trial summary
Recently, Mark Morris Dance Group, and created Moving Through Glass (MTG), a project that was funded by Google, as a portable, round-the-clock extension of the internationally acclaimed Dance for Parkinson's Disease (PD)®. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Parkinson Disease
- What is being tested?
- Moving Through Glass intervention
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 7 participants
- Where
- No sites listed yet
- Study dates
- 17 Oct 2016to 28 May 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- self-reported diagnosis of Parkinson's disease
- age 18 years or over
Who cannot join
- Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III> 57
- Montreal Cognitive Assessment (MOCA)<21,
- not being able to wear or operate Google Glass.
About this study
Official title: A Pilot Study to Evaluate the Augmented Reality-Based Dance Application on Mobility and Balance of Persons With Parkinson's Disease
Recently, Mark Morris Dance Group, and created Moving Through Glass (MTG), a project that was funded by Google, as a portable, round-the-clock extension of the internationally acclaimed Dance for Parkinson's Disease (PD)®. When a user activates Glass, participants can choose from a variety of different exercises, like "warm me up" or "balance me." Once selected, they see the founder instructors of the Dance for PD® projected in front of them.
As a single site research study at Syracuse University, researchers are conducting the pilot phase of the research project.
The purpose of the study is to investigate the impact of MTG on quality of life and motor functions (i.e. balance, gait, fall efficacy). Participation in the study required three visits to Women's Building in a period of four weeks and about 1-3 hours of the participant's time at each visit. During the first visit, 1 participants reviewed the consent form, completed Montreal Cognitive Assessment (MOCA) and if qualified participated in a face-to-face interview. Participants were given survey package to fill out at home and were given a week to complete all the paperwork. On the second visit, they returned the completed survey package, were given physical assessments and were taught how to use Google Glass. The participants left with Google Glass, log sheet, and survey package. After 3 weeks, participants came to Women's Building for the last visit and the physical assessments were repeated, followed by an exit interview.
Read the detailed description
The common symptoms of Parkinson's disease (PD) include but are not limited to resting tremor, muscular rigidity, and difficulty in initiating movement. These motor impairments, which can negatively impact the fluidity and pacing of movement, can increase the risk people with PD face in their daily activities. Additionally, non-motor symptoms such as apathy and depression can often lead to isolation, potentially reducing physical activity in people with PD.
In 2001, Dance for Parkinson's Disease (DfPD), a collaboration between Brooklyn Parkinson Group (BPG) and Mark Morris Dance Group (MMDG), an internationally known company based in Brooklyn, began providing dance classes for the Parkinson community to train other teachers in the hopes of developing cognitive strategies and to enhance the sense of community and the amount of physical activity in PD population. Since then, positive effects of dance in motor and cognitive functions of people with PD have been reported from several types of dance classes.
While recent research has investigated dance as a therapy for people with Parkinson's disease (PD), there is only one study, to our knowledge, that investigates the use of Google Glass as a portable way for persons with PD to use cued movement as they perform activities of daily living to help temporarily alleviate symptoms such as freezing, initiating movement, and balancing. This qualitative study explored the acceptability of the Google Glass in five participants with PD, as well as their caregivers. The results of this study showed that participants highly favored the voice activation system used to control this technology, especially in comparison to the frustrations expressed using touch screen smart phones. The participants also expressed increased confidence because the Google Glass gave them a sense of independence when going out into public alone. Despite the potential beneficial uses of the Glass, due to the highly complicated menus with multiple applications participants found using the Glass frustrating. Additionally, low number of participants used in this study, very short intervention time, and the lack of quantitative data suggests that further investigation of use of a simplified version of Google Glass in rehabilitation of Parkinson's disease is necessary.
Recently, MMDG created Moving Through Glass (MTG), a project that was funded by Google, as a portable, round-the-clock extension of the internationally acclaimed Dance for PD®. When a user activates Glass, they can choose from a variety of different exercises, like "warm me up" or "balance me." Once selected, they see the founder instructors of the Dance for PD® projected in front of them.
As a single site research study at Syracuse University, researchers will be conducting the pilot phase of the research project. MMDG provided the research team with the three pairs of glasses needed to complete this study. At the end of this study, the glasses will be returned to MMDG. The MTG questionnaire (described in detail in Section 4), provided by MMDG as part of their product development, will also be given to the participants to collect information about the product. MTG questionnaires, including only deidentified, gross data, will be shared with MMDG as a part of product development, not research. Researchers will NOT be reporting our research findings to Google or MMDG.
The purpose of the study is to investigate the impact of MTG on quality of life and motor functions (i.e. balance, gait, fall efficacy). Researchers are trying to answer the following questions:
Purpose #1: What are the Parkinson's disease patients' experiences (constraints, benefits, strategies, etc) related to physical activity?
Purpose #2: What is the participants' perception of using Google Glass during their daily activities? In topics related to:
- Perceived competence
- Movement independency
- Participation in physical activity
- Participation in social interactions
Participants in this study will be people with Parkinson's disease. Researchers plan to recruit 15 subjects in this project. Due to the limited number of Google Glasses (3 pairs), only 3 participants will go through the study at a given time period. Once recruited, the participants will be expected to make three visits to Women's Building at Syracuse University in a one-month period. On the first visit, researchers will go over the consent form with the participants. Upon signing the forms, participants will be asked to complete the Montreal Cognitive Assessment (MOCA, 10 min). The MOCA is shown to be a highly sensitive cognitive assessment even for mild cognitive impairment and is used widely with Parkinson's population. Researchers will use this assessment to have a cut-off point for the exclusion criteria for the participants who are in a high-risk group for dementia. The optimal cut-off value of 22 is determined on a 30-point scale, with 30 indicating no cognitive problems. The scale is comprised of 7 sub scores that include executive functioning, memory, naming, attention, language, abstraction, and orientation. If the inclusion criteria are met, the participants will also participate in a face-to-face semi-structured interview to explore their perception regarding movement strategies, fear of falling, patterns of physical recreation, perceived benefits, and constraints. This interview will occur before the implementation of the program. The duration of each interview will be between 60 to 75 minutes. This interview will be audio and video recorded. The purpose of video and audio recording of the interviews is to ensure that we capture the essential meaning of participants' experiences.
Once the interviews are completed, the participants will receive a package that includes several questionnaires and surveys.
- Conditions
- Parkinson Disease
- Being tested
- Moving Through Glass intervention
- Keywords
- Parkinson's disease, Dance, Google Glass, Mobility, Balance
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Moving Through Glass interventionDevice
| Study group | Role | What they receive |
|---|---|---|
| Moving Through Glass intervention | Experimental | Participants were asked to use Moving Through Glass (MTG) intervention on Google Glass for at least once a day for 3 weeks. MTG intervention includes 4 difference guided-dance/movement modules for the participants. Receives: Device: Moving Through Glass intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mobility
To assess the mobility of people with Parkinson's disease. This outcome will be measured using the Mini Balance Evaluations System Test (Mini-BESTest)
Measured: 3 weeks
Secondary outcomes (8)
Mood
To assess the depression levels of people with Parkinson's disease. This outcome will be measured using the Becks Depression Inventory (BDI)
Measured: 3 weeks
Quality of life of Participants
To assess the quality of life of people with Parkinson's disease. This outcome will be measured using the Parkinson's Disease Quality of Life questionnaire (PDQL)
Measured: 3 weeks
Google Glass experience-Questionnaire
To assess the experiences of persons with PD regarding the Google Glass use. This outcome will be measured using the Moving Through Glass questionnaire.
Measured: 3 weeks
Quantitative measures of the Google Glass experience
To assess the experiences of persons with PD regarding the Google Glass use. This outcome will be measured using quantitative participant report.
Measured: 3 weeks
Qualitative measures of the Google Glass experience
To assess the experiences of persons with PD regarding the Google Glass use. This outcome will be measured using qualitative participant interviews.
Measured: 3 weeks
Balance-MiniBestTEst
To assess the balance of people with Parkinson's disease. This outcome will be measured using the Mini Balance Evaluations System Test (Mini-BESTest)
Measured: 3 weeks
Balance-ABC
To assess the balance of people with Parkinson's disease. This outcome will be measured using the Activity-specific Balance Confidence scale (ABC)
Measured: 3 weeks
Physical activity
To assess the engagement in physical activity of people with Parkinson's disease. This outcome will be measured using the Physical Activity Scale for Elderly (PASE).
Measured: 3 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jul 2017
- Study start17 Oct 2016
- Primary completion28 May 2017
- Study completion28 May 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Device feasibility
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Prospective uncontrolled pilot study
- Masking
- None (open label)
- Enrolment
- 7 participants (actual)
Sponsor and investigators
- Lead sponsor
- Syracuse University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Luis Columna, Syracuse University
- Investigators
- Luis Columna, PhD, Principal investigator, Syracuse University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03214926
- Sponsor's protocol ID
- 16239
- Status last verified
- Nov 2018
- First submitted
- 7 Jul 2017
- Last updated
- 4 Dec 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Dec 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Pilot Study to Evaluate the Augmented Reality-Based Dance Application on Mobility and Balance of Persons With Parkinson's Disease
- ClinicalTrials.gov ID
- NCT03214926
- Acronym / sponsor ID
- 16239
- Conditions
- Parkinson Disease
- Keywords
- Parkinson's disease, Dance, Google Glass, Mobility, Balance
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 7 participants (actual)
- Lead sponsor
- Syracuse UniversityUniversity, hospital or other
- Study start
- 17 Oct 2016 (actual)
- Primary completion
- 28 May 2017 (actual)
- Study completion
- 28 May 2017 (actual)
- First posted
- 12 Jul 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Recently, Mark Morris Dance Group, and created Moving Through Glass (MTG), a project that was funded by Google, as a portable, round-the-clock extension of the internationally acclaimed Dance for Parkinson's Disease (PD)®. When a user activates Glass, participants can choose from a variety of different exercises, like "warm me up" or "balance me." Once selected, they see the founder instructors of the Dance for PD® projected in front of them.
As a single site research study at Syracuse University, researchers are conducting the pilot phase of the research project.
The purpose of the study is to investigate the impact of MTG on quality of life and motor functions (i.e. balance, gait, fall efficacy). Participation in the study required three visits to Women's Building in a period of four weeks and about 1-3 hours of the participant's time at each visit. During the first visit, 1 participants reviewed the consent form, completed Montreal Cognitive Assessment (MOCA) and if qualified participated in a face-to-face interview. Participants were given survey package to fill out at home and were given a week to complete all the paperwork. On the second visit, they returned the completed survey package, were given physical assessments and were taught how to use Google Glass. The participants left with Google Glass, log sheet, and survey package. After 3 weeks, participants came to Women's Building for the last visit and the physical assessments were repeated, followed by an exit interview.
Detailed description
The common symptoms of Parkinson's disease (PD) include but are not limited to resting tremor, muscular rigidity, and difficulty in initiating movement. These motor impairments, which can negatively impact the fluidity and pacing of movement, can increase the risk people with PD face in their daily activities. Additionally, non-motor symptoms such as apathy and depression can often lead to isolation, potentially reducing physical activity in people with PD.
In 2001, Dance for Parkinson's Disease (DfPD), a collaboration between Brooklyn Parkinson Group (BPG) and Mark Morris Dance Group (MMDG), an internationally known company based in Brooklyn, began providing dance classes for the Parkinson community to train other teachers in the hopes of developing cognitive strategies and to enhance the sense of community and the amount of physical activity in PD population. Since then, positive effects of dance in motor and cognitive functions of people with PD have been reported from several types of dance classes.
While recent research has investigated dance as a therapy for people with Parkinson's disease (PD), there is only one study, to our knowledge, that investigates the use of Google Glass as a portable way for persons with PD to use cued movement as they perform activities of daily living to help temporarily alleviate symptoms such as freezing, initiating movement, and balancing. This qualitative study explored the acceptability of the Google Glass in five participants with PD, as well as their caregivers. The results of this study showed that participants highly favored the voice activation system used to control this technology, especially in comparison to the frustrations expressed using touch screen smart phones. The participants also expressed increased confidence because the Google Glass gave them a sense of independence when going out into public alone. Despite the potential beneficial uses of the Glass, due to the highly complicated menus with multiple applications participants found using the Glass frustrating. Additionally, low number of participants used in this study, very short intervention time, and the lack of quantitative data suggests that further investigation of use of a simplified version of Google Glass in rehabilitation of Parkinson's disease is necessary.
Recently, MMDG created Moving Through Glass (MTG), a project that was funded by Google, as a portable, round-the-clock extension of the internationally acclaimed Dance for PD®. When a user activates Glass, they can choose from a variety of different exercises, like "warm me up" or "balance me." Once selected, they see the founder instructors of the Dance for PD® projected in front of them.
As a single site research study at Syracuse University, researchers will be conducting the pilot phase of the research project. MMDG provided the research team with the three pairs of glasses needed to complete this study. At the end of this study, the glasses will be returned to MMDG. The MTG questionnaire (described in detail in Section 4), provided by MMDG as part of their product development, will also be given to the participants to collect information about the product. MTG questionnaires, including only deidentified, gross data, will be shared with MMDG as a part of product development, not research. Researchers will NOT be reporting our research findings to Google or MMDG.
The purpose of the study is to investigate the impact of MTG on quality of life and motor functions (i.e. balance, gait, fall efficacy). Researchers are trying to answer the following questions:
Purpose #1: What are the Parkinson's disease patients' experiences (constraints, benefits, strategies, etc) related to physical activity?
Purpose #2: What is the participants' perception of using Google Glass during their daily activities? In topics related to:
- Perceived competence
- Movement independency
- Participation in physical activity
- Participation in social interactions
Participants in this study will be people with Parkinson's disease. Researchers plan to recruit 15 subjects in this project. Due to the limited number of Google Glasses (3 pairs), only 3 participants will go through the study at a given time period. Once recruited, the participants will be expected to make three visits to Women's Building at Syracuse University in a one-month period. On the first visit, researchers will go over the consent form with the participants. Upon signing the forms, participants will be asked to complete the Montreal Cognitive Assessment (MOCA, 10 min). The MOCA is shown to be a highly sensitive cognitive assessment even for mild cognitive impairment and is used widely with Parkinson's population. Researchers will use this assessment to have a cut-off point for the exclusion criteria for the participants who are in a high-risk group for dementia. The optimal cut-off value of 22 is determined on a 30-point scale, with 30 indicating no cognitive problems. The scale is comprised of 7 sub scores that include executive functioning, memory, naming, attention, language, abstraction, and orientation. If the inclusion criteria are met, the participants will also participate in a face-to-face semi-structured interview to explore their perception regarding movement strategies, fear of falling, patterns of physical recreation, perceived benefits, and constraints. This interview will occur before the implementation of the program. The duration of each interview will be between 60 to 75 minutes. This interview will be audio and video recorded. The purpose of video and audio recording of the interviews is to ensure that we capture the essential meaning of participants' experiences.
Once the interviews are completed, the participants will receive a package that includes several questionnaires and surveys.
Study design
- Primary purpose
- Device feasibility
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Prospective uncontrolled pilot study
| Arm | Type | Receives |
|---|---|---|
| Moving Through Glass intervention | Experimental | Device: Moving Through Glass interventionParticipants were asked to use Moving Through Glass (MTG) intervention on Google Glass for at least once a day for 3 weeks. MTG intervention includes 4 difference guided-dance/movement modules for the participants. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- self-reported diagnosis of Parkinson's disease
- age 18 years or over
Key exclusion criteria (3 listed)
- Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III> 57
- Montreal Cognitive Assessment (MOCA)<21,
- not being able to wear or operate Google Glass.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Moving Through Glass intervention | Device | Moving Through Glass intervention |
Primary outcome
Mobility
Time frame: 3 weeks
To assess the mobility of people with Parkinson's disease. This outcome will be measured using the Mini Balance Evaluations System Test (Mini-BESTest)
8 secondary outcomes
Mood
Time frame: 3 weeks
Quality of life of Participants
Time frame: 3 weeks
Google Glass experience-Questionnaire
Time frame: 3 weeks
Quantitative measures of the Google Glass experience
Time frame: 3 weeks
Qualitative measures of the Google Glass experience
Time frame: 3 weeks
Balance-MiniBestTEst
Time frame: 3 weeks
Balance-ABC
Time frame: 3 weeks
Physical activity
Time frame: 3 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Dec 2018.
- Individual participant dataSharing planned: No
Related trials for Parkinson Disease
RecruitingObservational study
Evaluation and Treatment of Neurosurgical Disorders
Neurologic Disorders
Enrolling by invitation
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease
Parkinson's Disease, Depression
RecruitingPhase 1/2
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Active, not recruitingPhase 2
A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
Thymoma, Thymic Carcinoma
Not yet recruitingObservational study
Twenty-five Years of Advanced RadioTherapy at San Raffaele Hospital
Malignant Tumor, Benign Neoplasm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Luis Columna, PhD principal investigator
Syracuse University
Questions about this trial
What is this clinical trial studying?
A study testing Moving Through Glass intervention in people with Parkinson Disease, run by Syracuse University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mobility (time frame: 3 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2018.